Clinical Trials Logo

Gambling Disorder clinical trials

View clinical trials related to Gambling Disorder.

Filter by:

NCT ID: NCT06467422 Not yet recruiting - Gambling Disorder Clinical Trials

Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder

Start date: June 20, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate the effect of transcranial temporal interference stimulation (tTIS) targeting the dorsal anterior cingulate cortex in patients with gambling disorder.

NCT ID: NCT06182137 Not yet recruiting - Gambling Disorder Clinical Trials

Repetitive Transcranial Magnetic Stimulation (rTMS) in The Treatment of Gambling Disorder in Indonesia

Start date: January 2024
Phase: N/A
Study type: Interventional

Research has shown that cognitive-behavioral therapy (CBT) is an effective treatment for gambling disorder. Several studies had also been done to evaluate the effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) in addiction management, particularly in alleviating craving. A randomised controlled trial (RCT) of 60 subjects would be conducted to evaluate the effectiveness of transmodalistic therapy with a combination of rTMS and CBT for online gambling disorder.

NCT ID: NCT06107621 Recruiting - Clinical trials for Comorbidities and Coexisting Conditions

iCBT for GD and Comorbidities - a Pilot

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The study is a pilot study (Total N=30), with at pre, weekly during treatment, post and at three-month follow-up.

NCT ID: NCT06099522 Recruiting - Gambling Disorder Clinical Trials

Internet-CBT for Gambling Disorder - a Randomized Controlled Trial

Start date: January 15, 2024
Phase: N/A
Study type: Interventional

The study is a randomized controlled trial (Total N=150; each condition n=75) of internet-based cognitive behavioral therapy (iCBT), with measures at pre, weekly during treatment, post, three and at six month follow-up. Participants will be assigned to either standard iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition).

NCT ID: NCT05872750 Recruiting - Gambling Disorder Clinical Trials

Theta Burst Stimulation for Gambling Disorder

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the efficacy of theta burst stimulation in individuals with gambling disorder. The main goal is to compare the severity of gambling problems following 2 weeks of intervention between active group and sham group. Participants will be randomized into active and sham group. The severity of gambling problems are assessed by self-reported questionaires.

NCT ID: NCT05854706 Recruiting - Gambling Disorder Clinical Trials

The Effect of Theta-burst Stimulation on Serum BDNF

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the effect of theta burst stimulation for depression and serum brain-derived neurotrophic factor (BDNF) in individuals with major depression. The main question it aims to answer is whether 10 sessions of theta burst stimulation can influence the serum level of BDNF. Participants will be randomized into active group and sham group. Researchers will compare the level of BDNF in these groups.

NCT ID: NCT05833503 Recruiting - Clinical trials for Substance Use Disorders

Integrative Couple Treatment for Gambling/Substance Use Disorder

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to compare couple-based treatment to individual treatment (treatment as usual) for addiction (gambling or substance use disorder).

NCT ID: NCT05693155 Recruiting - Gambling Disorder Clinical Trials

Experience of the Nationwide Gambling Self-exclusion Service Spelpaus - Effects and Limitations of a Unique Harm Reduction Instrument for Problem Gambling

Start date: February 13, 2023
Phase:
Study type: Observational

Qualitative interview study addressing the effects and limitations of a unique, government-based, nationwide self-exclusion service for the reduction of gambling-related harm. This service, which allows for individuals at risk of gambling problems (and for anyone) to self-exclude from all licensed gambling in the country, is unique in its nationwide, non-gambling-operator-dependent and multi-operator design. It is a promising tool for the prevention and harm reduction in relation to problem gambling and gambling disorder, but emerging research data report considerable limitations including high access to non-licensed gambling allowing users to breach the voluntary self-exclusion and relapse into hazardous gambling practices. This study will examine effects and limitations of the system, for gamblers and for concerned significant others of gamblers, through qualitative interviews addressing their experience of the system.

NCT ID: NCT05686772 Recruiting - Psychotic Disorders Clinical Trials

Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis

ANTE-UP
Start date: November 1, 2019
Phase:
Study type: Observational

The aim of this observational study is to get a better understanding of the association between problem gambling psychotic disorders among young adults with firs-episode psychosis. The main questions to be answered are: 1. What are the incidence and risk factors for problem gambling in this population? 2. How effective are the current treatments for problem gambling in adults with first-episode psychosis? To do so, comparisons will be made among the study cohort for various factors: - Use of dopamine partial agonists; - Psychiatric comorbidities; - Socioeconomic status; - Sex; - Gender; - Gambling history. The nature of the treatments for problem gambling offered and received by the subjects, as well as their effectiveness, will also be documented.

NCT ID: NCT05413564 Recruiting - Gambling Disorder Clinical Trials

Impact of a Self-Exclusion Procedure Optimized by an Extension of the Suspension of Commercial Solicitations

PASS
Start date: May 30, 2022
Phase: N/A
Study type: Interventional

Considering that self-exclusion from gambling on a particular website is an intervention for and by individuals who have developed a gambling disorder, it is currently exclusively a behavioural intervention in the sense that it prevents the behaviour Resumption of commercial solicitations only in the period when gambling is not accessible in the corresponding website , through voluntary self-exclusion (where the gambler prevents himself or herself from gambling), does not appear to be sufficient to prevent relapse. Early commercial solicitations, in the immediate intercourse after the end of the self-exlcusion period may precipitate relapse in gamblers whose behaviour change is by definition recent, and who have only received a behavioural measure. The investigators hypothesize an improved efficacy as measured by reduced gambling after a self-exclusion optimized by a period of suspension of commercial solicitations extended to 9 months, compared to self-exclusion with the standard procedure. Gamblers will be randomized according to an a priori randomization list.